{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:27:11Z","timestamp":1778758031326,"version":"3.51.4"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"abstract":"<jats:p>\n                    This study aimed to evaluate the changes in portal venous flow velocity before and after direct-acting antiviral (DAA) therapy in patients diagnosed with chronic hepatitis C (CHC). A total of 53 CHC patients (36 males, 17 females; mean age 61.8\u2005\u00b1\u20057.7 years) treated with DAA at the Gastroenterology Department of our institution were included, along with 55 healthy controls matched by age and sex. Portal vein flow velocity was measured using Doppler ultrasonography, before and after treatment. Biochemical parameters, aspartate aminotransferase to platelet ratio, and fibrosis-4 scores were also analyzed. The mean pretreatment portal vein velocities in patients before treatment were 12.1 m\/s and 17.5 m\/s in the control healthy individuals (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). DAA therapy resulted in a 100% sustained viral response. The posttreatment velocity increased significantly to 18 m\/s (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Aspartate aminotransferase and alanine aminotransferase levels were significantly decreased (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), while serum albumin levels were increased (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.008). Although the platelet count increased, the change was not statistically significant (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.232). Significant improvements were observed in aspartate aminotransferase to platelet ratio and fibrosis-4 scores (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). The cirrhotic and non-cirrhotic subgroups demonstrated significant increases in portal flow velocity and decreased fibrosis values. DAA therapy in CHC patients also improved portal hemodynamics and noninvasive fibrosis markers, suggesting a broader impact on liver health and portal circulation.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046147","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:01:21Z","timestamp":1764169281000},"page":"e46147","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of portal venous flow velocity before and after direct acting antiviral therapy in chronic hepatitis C: A cohort study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5210-734X","authenticated-orcid":false,"given":"Hale","family":"\u00c7olako\u011flu Er","sequence":"first","affiliation":[{"name":"Department of Radiology, Ankara G\u00fcven Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramazan Erdem","family":"Er","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Ankara University, School of Medicine, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah Emre","family":"Yildirim","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Abdullah Emre Yildirim, Memorial Bah\u00e7elievler Hospital, \u0130stanbul, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260514","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series.","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J Hepatol"},{"key":"R2-20260514","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.","volume":"370","author":"Afdhal","year":"2014","journal-title":"N Engl J Med"},{"key":"R3-20260514","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","article-title":"New hepatitis C therapies: the toolbox, strategies, and challenges.","volume":"146","author":"Pawlotsky","year":"2014","journal-title":"Gastroenterology"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/gut.2005.076646","article-title":"Treating viral hepatitis C: efficacy, side effects, and complications.","volume":"55","author":"Manns","year":"2006","journal-title":"Gut"},{"key":"R5-20260514","first-page":"784","article-title":"Patient-reported outcomes in chronic hepatitis C patients treated with different antiviral regimens: results from the PROP UP study.","volume":"65","author":"Younossi","year":"2016","journal-title":"J Hepatol"},{"key":"R6-20260514","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","article-title":"Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.","volume":"144","author":"Berzigotti","year":"2013","journal-title":"Gastroenterology"},{"key":"R7-20260514","first-page":"6","article-title":"Long-term outcomes after hepatitis C cure with direct-acting antivirals.","volume":"41","author":"D\u2019Ambrosio","year":"2021","journal-title":"Liver Int"},{"key":"R8-20260514","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","article-title":"Performance of transient elastography for the staging of liver fibrosis: a meta-analysis.","volume":"134","author":"Friedrich Rust","year":"2008","journal-title":"Gastroenterology"},{"key":"R9-20260514","first-page":"233","article-title":"Regression of liver fibrosis after HCV clearance: understanding the underlying mechanisms.","volume":"16","author":"Armandi","year":"2022","journal-title":"Hepatol Int"},{"key":"R10-20260514","first-page":"1549","article-title":"Non-invasive assessment of liver fibrosis by transient elastography in patients with chronic hepatitis C: a meta-analysis.","volume":"38","author":"Chen","year":"2018","journal-title":"Liver Int"},{"key":"R11-20260514","first-page":"872","article-title":"Non-invasive diagnosis of liver fibrosis after sustained virologic response in chronic hepatitis C.","volume":"65","author":"Pons","year":"2017","journal-title":"Hepatology"},{"key":"R12-20260514","first-page":"386","article-title":"Transient elastography and biomarkers in the evaluation of liver fibrosis.","volume":"51","author":"Iwaisako","year":"2021","journal-title":"Hepatol Res"},{"key":"R13-20260514","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/v16030371","article-title":"Effects of HCV clearance with direct-acting antivirals (DAAs) on liver stiffness, liver fibrosis stage and metabolic\/cellular parameters.","volume":"16","author":"Ferreira","year":"2024","journal-title":"Viruses"},{"key":"R14-20260514","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s12879-021-06053-3","article-title":"Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort.","volume":"21","author":"Quaranta","year":"2021","journal-title":"BMC Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:06:15Z","timestamp":1778756775000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":14,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046147","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2025-08-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}